Abstract: The present invention is in the therapeutic field of drugs for medical conditions relating to diabetes. More specifically the invention relates to insulin analogues of human insulin. The invention provides pharmaceutical compositions comprising such insulin analogues and the uses if the such analogues for the treatment or prevention of medical conditions relating to diabetes.
| # | Name | Date |
|---|---|---|
| 1 | 202247038309.pdf | 2022-07-04 |
| 2 | 202247038309-STATEMENT OF UNDERTAKING (FORM 3) [04-07-2022(online)].pdf | 2022-07-04 |
| 3 | 202247038309-SEQUENCE LISTING(PDF) [04-07-2022(online)].pdf | 2022-07-04 |
| 4 | 202247038309-SEQUENCE LISTING [04-07-2022(online)].txt | 2022-07-04 |
| 5 | 202247038309-PRIORITY DOCUMENTS [04-07-2022(online)].pdf | 2022-07-04 |
| 6 | 202247038309-POWER OF AUTHORITY [04-07-2022(online)].pdf | 2022-07-04 |
| 7 | 202247038309-FORM 1 [04-07-2022(online)].pdf | 2022-07-04 |
| 8 | 202247038309-DRAWINGS [04-07-2022(online)].pdf | 2022-07-04 |
| 9 | 202247038309-DECLARATION OF INVENTORSHIP (FORM 5) [04-07-2022(online)].pdf | 2022-07-04 |
| 10 | 202247038309-COMPLETE SPECIFICATION [04-07-2022(online)].pdf | 2022-07-04 |
| 11 | 202247038309-FORM 18 [05-07-2022(online)].pdf | 2022-07-05 |
| 12 | 202247038309-RELEVANT DOCUMENTS [15-12-2022(online)].pdf | 2022-12-15 |
| 13 | 202247038309-Proof of Right [15-12-2022(online)].pdf | 2022-12-15 |
| 14 | 202247038309-POA [15-12-2022(online)].pdf | 2022-12-15 |
| 15 | 202247038309-FORM 13 [15-12-2022(online)].pdf | 2022-12-15 |
| 16 | 202247038309-FORM 3 [21-12-2022(online)].pdf | 2022-12-21 |
| 17 | 202247038309-FORM 3 [07-06-2023(online)].pdf | 2023-06-07 |
| 18 | 202247038309-FORM-26 [20-10-2023(online)].pdf | 2023-10-20 |
| 19 | 202247038309-FORM 3 [06-12-2023(online)].pdf | 2023-12-06 |